Atlas Trials

Melanoma Unresectable

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Melanoma Unresectable

RecordFirmDate
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma (NCT05732805)Biocad2022-08-02

Track Melanoma Unresectable automatically

Every clearance here is in the API, with alerts when new ones post.